544 filings
Page 3 of 28
424B4
1chqmb8 2br9u
24 Apr 23
Prospectus supplement with pricing info
3:02pm
EFFECT
19g xgdxsj1ayf
20 Apr 23
Notice of effectiveness
12:15am
POS AM
3cxjb ty48xpaq
14 Apr 23
Prospectus update (post-effective amendment)
2:29pm
8-K
p4meja otoly48w4
4 Apr 23
Regulation FD Disclosure
2:26pm
8-K
t8gnt4wj
27 Mar 23
Entry into a Material Definitive Agreement
6:05am
8-K
hvfaqaf
17 Mar 23
BioLargo Continues Record Setting Revenue Growth
6:24pm
424B4
uxay 97asjpp
26 Jan 23
Prospectus supplement with pricing info
10:35am
EFFECT
n65i4ktg6exfjtthbm
20 Jan 23
Notice of effectiveness
12:15am
CORRESP
yjp9q3t7 7qm0s
17 Jan 23
Correspondence with SEC
12:00am
CORRESP
7zo0w9bm
6 Jan 23
Correspondence with SEC
12:00am
CORRESP
s6a5hb 2z84v0sz
4 Jan 23
Correspondence with SEC
12:00am
UPLOAD
vzoc8 y8a2ts1p07
3 Jan 23
Letter from SEC
12:00am
8-K
3ionfflvlaj
19 Dec 22
Entry into a Material Definitive Agreement
4:19pm
8-K
ylioomd6w
3 Nov 22
BioLargo Adds Linda Park and Christina Bray to Board of Directors
6:10am
8-K
0ufta29scrngvb qzcf
31 Oct 22
BioLargo Sets Another New Quarterly Revenue Record
3:58pm